Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer (TNBC)

Explore clinical trials studying Triple Negative Breast Cancer (TNBC). Study availability and eligibility vary by location and protocol.

54 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer (TNBC) trial results

Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • City of Hope Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Irvine, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

NCT07545122

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +16 more
Locations
  • Tasman Oncology Research Gold Coast, Queensland, Australia
  • Calvary Mater Hospital Newcastle Newcastle, Queensland, Australia
  • Linear Clinical Research Perth, Western Australia, Australia
  • Sydney Adventist Hospital Wahroonga, New South Wales, Australia
View Trial Details
Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

NCT07029399

Conditions
Breast Diseases, Breast Neoplasms, CCNE1 Amplified Advanced Solid Tumors, +12 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

NCT07743190

Conditions
Breast Diseases, Breast Neoplasms, Elevated Tumor-Infiltrating Lymphocytes, +6 more
Locations
  • SUNY Upstate Medical University Syracuse, New York, United States
  • Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States
View Trial Details
Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Normunity Investigational Site Denver, Colorado, United States
  • Normunity Investigational Site New Haven, Connecticut, United States
  • Normunity Investigational Site Minneapolis, Minnesota, United States
  • Normunity Investigational Site Maumee, Ohio, United States
View all 18 locations
View Trial Details

Related conditions